The Company has disclosed Business Segments as the primary segments.
 Segments have been identified taking into account the nature of the
 products, the differing risks and returns, the organizational structure
 and the internal reporting system.
 
 Primary Business segments
 
 As per Accounting Standard 1 7 (Segment Reporting), the primary
 reporting of the Company based on business segments are classified as
 Specialty Chemicals and Others. Specialty Chemicals includes
 coating chemicals, additives, water treatment and paper treatment
 chemicals, home and fabric care chemicals and personal care chemicals.
 
 Other Segments represent manufacturing under contract and sourcing of
 products for exports.
 
 Geographical segments
 
 Secondary segmental reporting is based on the geographical location of
 customers. The geographical segments have been disclosed based on
 revenues within India (sales to customers in India) and revenues
 outside India (sales to customer located outside India).
 
 Segment revenue and result
 
 These include income/expenses that are directly attributable to the
 Segment or are allocated on appropriate basis. The income/expenses that
 are not directly attributable to the business segments are shown as
 unallocated cost.
 
 Segment assets and liabilities
 
 The segment assets include all operating assets used by a segment and
 consist principally of debtors, inventories, advances and fixed assets,
 net of allowances. Assets at the corporate level are not allocable to
 segments on a reasonable basis and thus the same have not been
 allocated.
 
 Segment liabilities include all operating liabilities and consist
 principally of creditors and accrued liabilities.
 
 1.  RELATED PARTY DISCLOSURES 
 
 (a) Parties where control exists:
 
 Holding Company:
 
 Ciba Holding Inc., Switzerland
 
 - Holds 69.28% equity shares in the Company.  (58.28% held directly and
 11% through its ultimate subsidiary Ciba Research (India) Private
 Limited)
 
 Subsidiaries:
 
 Diamond Dye-Chem Limited  -  a wholly owned subsidiary of the Company.
 
 Virchow Drugs Limited     -  51% equity shares (ceases to be a 
                              subsidiary w.e.f. March 31, 2009)
 
 (b) Related party relationships where transactions have taken place
 during the year: Fellow Subsidiaries:
 
 Ciba Inc., Switzerland
 
 Ciba SA, France
 
 Ciba Grenzach GmbH, Germany
 
 Ciba (Taiwan) Ltd.
 
 Ciba (Maastricht) B.V., Netherlands
 
 Ciba UK PLC, UK
 
 Ciba Especialidades Quimicas Ltda., Brazil
 
 Ciba Corporation, USA
 
 Ciba OY, Finland
 
 Ciba (Shanghai) Ltd., China
 
 Ciba K K, Japan
 
 Ciba Middle East W.LL Bahrain
 
 Ciba (Hong kong) Ltd.
 
 Shanghai Ciba Gao-Qiao Chemical  Co. Ltd., China
 
 Ciba Korea Ltd.
 
 Ciba Specialty Chemicals Services Inc., Istanbul
 
 Ciba (Singapore) Pte Ltd., Singapore
 
 Ciba Specialty Chemicals (PTY) Ltd., South Africa
 
 Ciba Especialidades Quimicas, S.A, Colombia
 
 Ciba S.A. de C.V., Mexico
 
 PT Latexia, Indonesia
 
 Chemipro Fine chemicals Kaisha Ltd., Japan
 
 Ciba Research (India) Private Limited
 
 Polyad Services GMBH Germany
 
 Ciba Especialidades Quimicas, Guatemala.
 
 Director
 
 C. Newton - Managing Director
 
 2.  EXCEPTIONAL ITEMS
 
 (a) In the current year the company has changed the method of
 depreciation with retrospective effect from Written Down Value Method
 to Straight Line Method. The differential depreciation for the earlier
 period due to change in depreciation method Rs. 109,936 /- (net of tax
 Rs. 72569/-) is written back to the Profit and Loss account the same is
 disclosed as an exceptional item for the current year.
 
 (b) Company sold the investment in its subsidiary Virchow Drugs
 Limited during the current year. The loss incurred on sale Rs. 40,547/-
 ( net of tax Rs. 40,547/-) is disclosed as an exceptional item.
 
 3.  EMPLOYEE BENEFITS
 
 The Company has adopted Accounting Standard 15 (AS-15) (Revised)
 Employee benefits which is mandatory from accounting periods starting
 from December 7, 2006. Accordingly, the Company has provided for
 gratuity and leave encashment based on actuarial valuation done as per
 Projected Unit Credit Method.
 
 (a) Defined Benefit Plan
 
 i.  Salary Escalation Rate
 
 The estimates of future salary increases considered in actuarial
 valuation takes into account inflation, seniority, promotion and other
 relevant factors, such as supply and demand in the employment market.
 
 ii.  Basis used to determine Expected Rate of Return on Plan Assets
 
 The expected rate of return on Plan Assets is based on expectation of
 the average long term rate of return expected on investments of the
 fund during the estimated term of the obligations.
 
 iii.  The Company expects to contribute Rs. 4,000 to gratuity in next
 year.
 
 (b) Defined Contribution Plans
 
 Amount recognized as an expense and included in the Schedule 16 -
 Contributions to Provident and other funds of Profit and Loss account
 - Rs. 32,047 (Previous year Rs. 25,1 36).
 
 There is no other obligation other than the Contribution payable to the
 respective trusts.
 
 4.  EARNINGS PER SHARE
 
 Basic and diluted earnings per share are calculated by dividing the net
 profit or loss for the year attributable to equity shareholders by the
 weighted average number of equity shares outstanding during the year.
 The Company has not issued any potential equity shares, accordingly,
 basic and diluted earnings per share are the same.
 
 5.  CONTINGENT LIABILITIES
 
                                     2009           2008
 Claims against the company not 
 acknowledged as debts
 
 Bank Guarantee                      30,110         28,783
 
 Income Tax                          12,814         12,814
 
 Central excise claims                 3013         20,223*
 
 Customs Duty                            -          52,992
 
                                     45,937        114,812
 
 * The Company has filed an appeal before the CESTAT against the order
 received from Commissioner of Customs (Imports) and Commissioner of
 Central Excise for demand of duty and penalty thereon.
 
 6.  SUPPLEMENTARY PROFIT AND LOSS DATA
 
 (I) Based on the information available with the company there are no
 Micro, Small and Medium Enterprise as defined in The Micro, Small and
 Medium Enterprise Development Act, 2006, to whom the Company owes dues
 on account of principal amount together with interest and accordingly
 no additional disclosure has been made.
 
 7.  The Company has fixed assets on the leased premises at Goa. The
 carrying value of fixed assets at the said leased premises Rs. 120,633
 including the assets which cannot be moved is Rs. 70,1 77 as at the
 year end. The lease of the premises expired on August 31, 2008 and
 pending the final outcome of the Companys negotiations in respect of
 the same, no impairment is assessed on the fixed assets at the leased
 premises and depreciation on these assets is provided as per the
 Companys policy. The company has relied on independent valuation
 report of January, 2008 and as the value of assets is more than the
 carrying value, no impairment is deemed necessary.
 
 8.  PRIOR YEAR COMPARATIVES
 
 Previous year figures are regrouped wherever necessary to conform to
 this years classification.